Related Experiment Video
Updated: Jun 14, 2025
High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
Published on: December 20, 2024
Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome
Siri H Strand1, Kathleen E Houlahan2,3, Vernal Branch4
1Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Background:
Ductal carcinoma in situ (DCIS) is a non-obligate precursor to invasive breast cancer (IBC). Studies have indicated differences in DCIS outcome based on race or ethnicity, but molecular differences have not been investigated.
Methods:
We examined the molecular profile of DCIS by self-reported race (SRR) and outcome groups in Black (n = 99) and White (n = 191) women in a large DCIS case-control cohort study with longitudinal follow up.
Results:
Gene expression and pathway analyses suggested that different genes and pathways are involved in diagnosis and ipsilateral breast outcome (DCIS or IBC) after DCIS treatment in White versus Black women. We identified differences in ER and HER2 expression, tumor microenvironment composition, and copy number variations by SRR and outcome groups.
Conclusions:
Our results suggest that different molecular mechanisms drive initiation and subsequent ipsilateral breast events in Black versus White women.
